Table 9. KNN classification-based predictions of GS with subsets of 30,000 cells and Biomarkers I.
A | Classification | ||||
---|---|---|---|---|---|
ID | B | 3+3 | 3+4 | 4+3 | Total |
HPrEpiC | 1,672 | 166 | 33 | 195 | 2,066 |
% | 80.93 | 8.03 | 1.6 | 9.44 | 100 |
LNCaP | 85 | 507 | 13,482 | 3,363 | 17,437 |
% | 0.49 | 2.91 | 77.32 | 19.29 | 100 |
B | Classification | ||||
ID | B | 3+3 | 3+4 | 4+3 | Total |
Patient 5 | 0 | 67 | 6,323 | 5,195 | 11,585 |
% | 0 | 0.58 | 54.58 | 44.84 | 100 |
Patient Z | 222 | 792 | 3,500 | 4,860 | 9,374 |
% | 2.37 | 8.45 | 37.34 | 51.85 | 100 |
C | Classification | ||||
Phase | B | 3+3 | 3+4 | 4+3 | Total |
B1 | 254 | 329 | 539 | 1,597 | 2,719 |
% | 9.34 | 12.1 | 19.82 | 58.73 | 100 |
% | 1.71 | 2.67 | 26.58 | 69.04 | 100 |
D | Classification | ||||
ID | B | 3+3 | 3+4 | 4+3 | Total |
Patient 7 | 13 | 117 | 1,705 | 3,794 | 5,629 |
% | 0.23 | 2.08 | 30.29 | 67.4 | 100 |
Patient 8 | 183 | 1,176 | 3,086 | 4,070 | 8,515 |
% | 2.15 | 13.81 | 36.24 | 47.8 | 100 |